Name | Number of supported studies | Average coverage | |
---|---|---|---|
endothelial cell | 13 studies | 31% ± 10% | |
astrocyte | 11 studies | 30% ± 13% | |
oligodendrocyte | 11 studies | 31% ± 11% | |
glutamatergic neuron | 10 studies | 43% ± 25% | |
macrophage | 10 studies | 30% ± 11% | |
oligodendrocyte precursor cell | 9 studies | 28% ± 12% | |
microglial cell | 8 studies | 25% ± 7% | |
dendritic cell | 8 studies | 31% ± 9% | |
GABAergic neuron | 8 studies | 41% ± 23% | |
adipocyte | 7 studies | 24% ± 6% | |
epithelial cell | 6 studies | 33% ± 14% | |
retinal cone cell | 6 studies | 20% ± 5% | |
myeloid cell | 5 studies | 29% ± 15% | |
mast cell | 5 studies | 21% ± 6% | |
monocyte | 5 studies | 37% ± 9% | |
type I pneumocyte | 5 studies | 22% ± 4% | |
type II pneumocyte | 5 studies | 25% ± 6% | |
classical monocyte | 4 studies | 21% ± 3% | |
neuron | 4 studies | 30% ± 15% | |
cardiac muscle cell | 4 studies | 21% ± 2% | |
ciliated cell | 4 studies | 27% ± 7% | |
club cell | 4 studies | 20% ± 3% | |
endothelial cell of lymphatic vessel | 4 studies | 26% ± 5% | |
interneuron | 4 studies | 54% ± 24% | |
hematopoietic precursor cell | 3 studies | 42% ± 35% | |
GABAergic interneuron | 3 studies | 25% ± 4% | |
retinal rod cell | 3 studies | 19% ± 3% | |
hepatocyte | 3 studies | 34% ± 21% | |
retinal pigment epithelial cell | 3 studies | 37% ± 13% | |
ependymal cell | 3 studies | 36% ± 10% | |
megakaryocyte-erythroid progenitor cell | 3 studies | 27% ± 11% | |
T cell | 3 studies | 18% ± 0% | |
alveolar macrophage | 3 studies | 45% ± 10% | |
fibroblast | 3 studies | 23% ± 7% | |
lymphocyte | 3 studies | 23% ± 4% | |
transit amplifying cell | 3 studies | 34% ± 25% | |
granule cell | 3 studies | 27% ± 6% | |
mucus secreting cell | 3 studies | 26% ± 7% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 100% | 2076.77 | 1445 / 1445 | 100% | 29.19 | 183 / 183 |
prostate | 100% | 1940.51 | 245 / 245 | 100% | 28.34 | 501 / 502 |
thymus | 100% | 3330.68 | 653 / 653 | 100% | 35.06 | 602 / 605 |
pancreas | 100% | 1962.77 | 328 / 328 | 99% | 19.08 | 177 / 178 |
breast | 100% | 1941.67 | 459 / 459 | 99% | 27.40 | 1111 / 1118 |
brain | 100% | 2669.86 | 2634 / 2642 | 99% | 18.67 | 701 / 705 |
lung | 99% | 1677.09 | 575 / 578 | 99% | 23.20 | 1149 / 1155 |
intestine | 100% | 1930.15 | 966 / 966 | 98% | 27.28 | 519 / 527 |
stomach | 100% | 1399.53 | 359 / 359 | 98% | 24.12 | 281 / 286 |
ovary | 100% | 1231.00 | 180 / 180 | 98% | 16.01 | 421 / 430 |
kidney | 100% | 2028.82 | 89 / 89 | 98% | 28.19 | 880 / 901 |
bladder | 100% | 1596.62 | 21 / 21 | 97% | 17.40 | 490 / 504 |
skin | 100% | 2984.34 | 1809 / 1809 | 96% | 23.24 | 455 / 472 |
uterus | 100% | 1381.27 | 170 / 170 | 95% | 19.43 | 438 / 459 |
liver | 98% | 1036.00 | 222 / 226 | 86% | 10.39 | 348 / 406 |
adrenal gland | 100% | 1358.17 | 258 / 258 | 66% | 5.75 | 152 / 230 |
muscle | 100% | 3035.22 | 803 / 803 | 0% | 0 | 0 / 0 |
spleen | 100% | 1416.30 | 241 / 241 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 100% | 5.17 | 1 / 1 |
adipose | 100% | 1936.58 | 1203 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 1701.21 | 1333 / 1335 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 98% | 27.53 | 44 / 45 |
peripheral blood | 97% | 1868.53 | 902 / 929 | 0% | 0 | 0 / 0 |
heart | 95% | 1519.88 | 820 / 861 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 95% | 18.65 | 76 / 80 |
lymph node | 0% | 0 | 0 / 0 | 93% | 10.82 | 27 / 29 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0002931 | Biological process | response to ischemia |
GO_0006897 | Biological process | endocytosis |
GO_0007169 | Biological process | cell surface receptor protein tyrosine kinase signaling pathway |
GO_0070527 | Biological process | platelet aggregation |
GO_0007165 | Biological process | signal transduction |
GO_0010595 | Biological process | positive regulation of endothelial cell migration |
GO_0060055 | Biological process | angiogenesis involved in wound healing |
GO_0010628 | Biological process | positive regulation of gene expression |
GO_0046854 | Biological process | phosphatidylinositol phosphate biosynthetic process |
GO_0006935 | Biological process | chemotaxis |
GO_0006874 | Biological process | intracellular calcium ion homeostasis |
GO_1903671 | Biological process | negative regulation of sprouting angiogenesis |
GO_0001952 | Biological process | regulation of cell-matrix adhesion |
GO_0035022 | Biological process | positive regulation of Rac protein signal transduction |
GO_0048015 | Biological process | phosphatidylinositol-mediated signaling |
GO_2000369 | Biological process | regulation of clathrin-dependent endocytosis |
GO_0030168 | Biological process | platelet activation |
GO_0051898 | Biological process | negative regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction |
GO_0036092 | Biological process | phosphatidylinositol-3-phosphate biosynthetic process |
GO_0003376 | Biological process | sphingosine-1-phosphate receptor signaling pathway |
GO_0007186 | Biological process | G protein-coupled receptor signaling pathway |
GO_0033031 | Biological process | positive regulation of neutrophil apoptotic process |
GO_0007156 | Biological process | homophilic cell adhesion via plasma membrane adhesion molecules |
GO_0010508 | Biological process | positive regulation of autophagy |
GO_0001935 | Biological process | endothelial cell proliferation |
GO_0045429 | Biological process | positive regulation of nitric oxide biosynthetic process |
GO_0043409 | Biological process | negative regulation of MAPK cascade |
GO_0043491 | Biological process | phosphatidylinositol 3-kinase/protein kinase B signal transduction |
GO_0040016 | Biological process | embryonic cleavage |
GO_1900747 | Biological process | negative regulation of vascular endothelial growth factor signaling pathway |
GO_0006914 | Biological process | autophagy |
GO_0016310 | Biological process | phosphorylation |
GO_1903298 | Biological process | negative regulation of hypoxia-induced intrinsic apoptotic signaling pathway |
GO_0016477 | Biological process | cell migration |
GO_0005730 | Cellular component | nucleolus |
GO_0030496 | Cellular component | midbody |
GO_0005886 | Cellular component | plasma membrane |
GO_0005942 | Cellular component | phosphatidylinositol 3-kinase complex |
GO_0005654 | Cellular component | nucleoplasm |
GO_0005943 | Cellular component | phosphatidylinositol 3-kinase complex, class IA |
GO_0005829 | Cellular component | cytosol |
GO_0005737 | Cellular component | cytoplasm |
GO_0043231 | Cellular component | intracellular membrane-bounded organelle |
GO_0005634 | Cellular component | nucleus |
GO_0106310 | Molecular function | protein serine kinase activity |
GO_0043560 | Molecular function | insulin receptor substrate binding |
GO_0005524 | Molecular function | ATP binding |
GO_0016301 | Molecular function | kinase activity |
GO_0016303 | Molecular function | 1-phosphatidylinositol-3-kinase activity |
GO_0035005 | Molecular function | 1-phosphatidylinositol-4-phosphate 3-kinase activity |
GO_0005515 | Molecular function | protein binding |
GO_0046934 | Molecular function | 1-phosphatidylinositol-4,5-bisphosphate 3-kinase activity |
Gene name | PIK3CB |
Protein name | Phosphatidylinositol 3-kinase catalytic subunit type 3 (Phosphoinositide-3-kinase class 3) Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform (PI3-kinase subunit beta) (PI3K-beta) (PI3Kbeta) (PtdIns-3-kinase subunit beta) (EC 2.7.1.153) (Phosphatidylinositol 4,5-bisphosphate 3-kinase 110 kDa catalytic subunit beta) (PtdIns-3-kinase subunit p110-beta) (p110beta) (Serine/threonine protein kinase PIK3CB) (EC 2.7.11.1) Phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta PIK3CB protein |
Synonyms | PIK3C1 DKFZp779K1237 |
Description | FUNCTION: Phosphoinositide-3-kinase (PI3K) phosphorylates phosphatidylinositol derivatives at position 3 of the inositol ring to produce 3-phosphoinositides . Uses ATP and PtdIns(4,5)P2 (phosphatidylinositol 4,5-bisphosphate) to generate phosphatidylinositol 3,4,5-trisphosphate (PIP3) . PIP3 plays a key role by recruiting PH domain-containing proteins to the membrane, including AKT1 and PDPK1, activating signaling cascades involved in cell growth, survival, proliferation, motility and morphology. Involved in the activation of AKT1 upon stimulation by G-protein coupled receptors (GPCRs) ligands such as CXCL12, sphingosine 1-phosphate, and lysophosphatidic acid. May also act downstream receptor tyrosine kinases. Required in different signaling pathways for stable platelet adhesion and aggregation. Plays a role in platelet activation signaling triggered by GPCRs, alpha-IIb/beta-3 integrins (ITGA2B/ ITGB3) and ITAM (immunoreceptor tyrosine-based activation motif)-bearing receptors such as GP6. Regulates the strength of adhesion of ITGA2B/ ITGB3 activated receptors necessary for the cellular transmission of contractile forces. Required for platelet aggregation induced by F2 (thrombin) and thromboxane A2 (TXA2). Has a role in cell survival. May have a role in cell migration. Involved in the early stage of autophagosome formation. Modulates the intracellular level of PtdIns3P (phosphatidylinositol 3-phosphate) and activates PIK3C3 kinase activity. May act as a scaffold, independently of its lipid kinase activity to positively regulate autophagy. May have a role in insulin signaling as scaffolding protein in which the lipid kinase activity is not required. May have a kinase-independent function in regulating cell proliferation and in clathrin-mediated endocytosis. Mediator of oncogenic signal in cell lines lacking PTEN. The lipid kinase activity is necessary for its role in oncogenic transformation. Required for the growth of ERBB2 and RAS driven tumors. Has also a protein kinase activity showing autophosphorylation . . |
Accessions | ENST00000483968.5 F8WDJ8 H0Y871 ENST00000289153.6 ENST00000477593.5 H7C565 ENST00000473435.1 ENST00000465581.1 C9JYX0 ENST00000544716.5 H7C5C3 Q6PJ60 ENST00000462294.1 ENST00000674063.1 Q68DL0 P42338 C9J345 H7C527 ENST00000469284.6 ENST00000462898.5 ENST00000493568.5 |